- Home
- MDGL vs HRL Comparison
MDGL vs HRL Comparison
Compare MDGL & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | HRL |
|---|---|---|
| Founded | 2011 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.8B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MDGL | HRL |
|---|---|---|
| Price | $521.03 | $20.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $674.45 | $26.50 |
| AVG Volume (30 Days) | 360.0K | ★ 3.9M |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 5.61% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | $180,133,000.00 | ★ $12,106,160,000.00 |
| Revenue This Year | $58.39 | $2.72 |
| Revenue Next Year | $47.10 | $1.83 |
| P/E Ratio | ★ N/A | $63.26 |
| Revenue Growth | N/A | ★ 1.55 |
| 52 Week Low | $265.00 | $20.62 |
| 52 Week High | $615.00 | $31.43 |
Technical Indicators
Market Signals| Indicator | MDGL | HRL |
|---|---|---|
| Relative Strength Index (RSI) | 62.15 | 27.57 |
| Support Level | $411.87 | N/A |
| Resistance Level | $610.00 | $24.62 |
| Average True Range (ATR) | 26.99 | 0.47 |
| MACD | 3.75 | -0.12 |
| Stochastic Oscillator | 64.35 | 7.79 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About HRL Hormel Foods Corporation
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (5.9%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.